Artificial ribonucleases:: Efficient and specific in vitro cleavage of human c-raf-1 RNA

被引:31
作者
Canaple, L
Hüsken, D
Hall, J
Häner, R
机构
[1] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland
[2] Novartis Pharma AG, Funct Genom, Basel, Switzerland
关键词
D O I
10.1021/bc0200024
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We report here the first successful sequence-specific cleavage of large RNA using artificial ribonucleases. A series of uniformly 2'-methoxyethoxy-modified oligonucleotides bearing a europium complex were investigated as artificial ribonucleases specific for the human c-raf-1 mRNA. The efficiency and specificity of these oligonucleotide-metal conjugates to bind and to cleave 571 and 2977 nucleotides long c-raf-1 RNA transcripts in vitro in a sequence-specific manner is demonstrated. Quantitative analysis reveals a cleavage efficiency of 60-70% within 4 h at 37degreesC. Precise mapping of cleavage sites using primer extension analysis shows that cleavage generally occurs at two or three major sites adjacent to the 3'-end of the RNA target region. Cleavage is preferentially observed after purine nucleotides. This study demonstrates the potency of artificial ribonucleases targeting large, biologically relevant RNAs.
引用
收藏
页码:945 / 951
页数:7
相关论文
共 27 条
[21]   Mitogen-activated protein kinase pathways [J].
Robinson, MJ ;
Cobb, MH .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :180-186
[22]   ACTIVATION OF HUMAN RAF TRANSFORMING GENES BY DELETION OF NORMAL AMINO-TERMINAL CODING SEQUENCES [J].
STANTON, VP ;
COOPER, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (03) :1171-1179
[23]   ONCOGENE ACTIVATION - C-RAF-1 GENE-MUTATIONS IN EXPERIMENTAL AND NATURALLY-OCCURRING TUMORS [J].
STORM, SM ;
RAPP, UR .
TOXICOLOGY LETTERS, 1993, 67 (1-3) :201-210
[24]   Inorganic mimics of ribonucleases and ribozymes: From random cleavage to sequence-specific chemistry to catalytic antisense drugs [J].
Trawick, BN ;
Daniher, AT ;
Bashkin, JK .
CHEMICAL REVIEWS, 1998, 98 (03) :939-960
[25]   Modified oligonucleotides: Synthesis and strategy for users [J].
Verma, S ;
Eckstein, F .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :99-134
[26]  
Zellweger T, 2001, J PHARMACOL EXP THER, V298, P934
[27]  
ZUKER M, 1989, METHOD ENZYMOL, V180, P262